Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death-Reference-Cited by-同舟云学术

Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death

Published:2023-11 Issue: Volume:197 Page:106945
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Lin Chih-Peng,Wu Shu-Hui,Lin Tzu-Yin,Chu Chia-Hui,Lo Leu-Wei,Kuo Ching-Chuan,Chang Jang-Yang,Hsu Szu-Chun,Ko Bor-Sheng,Yao Ming,Hsiao Jong-Kai,Wang Shih-Wei,Huang Dong-Ming

Funder

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Taiwan Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Pharmacology

Reference37 articles.

1. The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles, micelles, liposomes and exosomes;Palazzolo;Curr. Med. Chem.,2018

2. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance;Yao;Front. Mol. Biosci.,2020

3. Targeting multidrug resistance in cancer;Szakács;Nat. Rev. Drug Discov.,2006

4. Nanopreparations to overcome multidrug resistance in cancer;Patel;Adv. Drug Deliv. Rev.,2013

5. Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting;Murakami;Sci. Transl. Med.,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing PD-1 cell membrane-coated paclitaxel dimer nanoparticles for potentiated chemoimmunotherapy;Biomedicine & Pharmacotherapy;2024-05

2. Exploring doxorubicin transport in 2D and 3D models of MDA-MB-231 sublines: impact of hypoxia and cellular heterogeneity on doxorubicin accumulation in cells;American Journal of Cancer Research;2024